Patent Yard Sign in
Canadian application, no grantCanada

Modulation of immune responses

CA 2304119 A1 · Owner: Schillack, Volker Reinhard · Inventors: Du Preez, Gabriel Johannes; Schillack, Volker Reinhard; Van Den Bogaarden, Johannes Beyers

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method of affecting or modulating for stimulation or suppression of the immune cell product pursuant to an immune response to an external or endogenous immune stimulant in an animal comprising the steps of administering to such animal a non-toxic immune modulating effective quantity of a compound selected from the group consisting of compounds of the general chemical formula (I) R1-CO-NR2R3 wherein R1 is selected from the group consisting of H and lower (i.e. C1 to C3) alkyl and C2 to C3 alkenyl groups; R2 and R3 are the same or different and each is selected from the group consisting of H lower , (i.e. C1 to C3) alkyl and C2 to C3 alkenyl groups which may optionally be …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 16, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 16, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 16, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 16, 1998
GrantedNo grant recorded
Term endedSeptember 16, 2018
Patent numberCA 2304119 A1
Classification (IPC)A61K31/67 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedSep 16, 1998Term endedSep 16, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.